Medpace Holdings, Inc. (MEDP) shareholders
Close on Nov 17, 2026Market cap $18.27BP/E 36.2Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| August J. Troendle Joint filing with Medpace Investors, LLC (16.80%) | 5,396,508 | 19.10% | 13D (active) amendment | Sep 24, 2026 |
| BlackRock, Inc. | 2,417,994 | 7.90% | 13G (passive) amendment | Dec 31, 2023 |
| T. Rowe Price Associates, Inc. | 2,069,679 | 7.20% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of MEDP | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2,498,248 | 8.93% | $1.32B | +27,808 | 0.02% |
| Price T Rowe Associates Inc /Md/ | 2,069,677 | 7.40% | $1.10B | +1,780,170 | 0.11% |
| Aqr Capital Management LLC | 1,278,935 | 4.57% | $677.31M | −74,902 | 0.24% |
| Vanguard Portfolio Management LLC | 1,133,357 | 4.05% | $600.21M | +11,668 | 0.03% |
| Vanguard Capital Management LLC | 1,026,820 | 3.67% | $543.79M | +15,749 | 0.01% |
| State Street Corp | 710,895 | 2.54% | $376.48M | +28,666 | 0.01% |
| Geode Capital Management, LLC | 710,465 | 2.54% | $376.31M | −34,641 | 0.02% |
| Wasatch Advisors LP | 636,595 | 2.28% | $337.13M | −137,336 | 2.21% |
| Invesco Ltd. | 579,241 | 2.07% | $306.76M | +1,667 | 0.02% |
| Baillie Gifford & Co | 473,211 | 1.69% | $250.61M | −29,980 | 0.23% |
| Arrowstreet Capital, Limited Partnership | 429,012 | 1.53% | $227.20M | +33,243 | 0.10% |
| Renaissance Technologies LLC | 415,588 | 1.49% | $220.09M | −89,080 | 0.30% |
| Dimensional Fund Advisors LP | 397,500 | 1.42% | $210.52M | +49,015 | 0.04% |
| Morgan Stanley | 317,548 | 1.14% | $168.17M | +29,126 | 0.01% |
| UBS Group AG | 303,926 | 1.09% | $160.96M | −36,507 | 0.02% |
| Bessemer Group Inc | 282,897 | 1.01% | $149.82M | −2,534 | 0.21% |
| Mawer Investment Management Ltd. | 267,175 | 0.96% | $141.49M | −178,929 | 0.96% |
| Epoch Investment Partners, Inc. | 266,547 | 0.95% | $141.16M | +125,588 | 0.80% |
| TD Asset Management Inc | 263,872 | 0.94% | $139.74M | +130,819 | 0.12% |
| Thrivent Financial for Lutherans | 256,341 | 0.92% | $135.76M | +24,849 | 0.23% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 696 | 25M | 88.3% | 73 / 205 | 307 / 100 | 4M | 3M |
| Q1 2026 | 733 | 24M | 86.2% | 87 / 237 | 300 / 134 | 5M | 3M |
| Q4 2025 | 787 | 24M | 85.3% | 180 / 262 | 259 / 53 | 3M | 3M |
| Q3 2025 | 673 | 24M | 86.4% | 139 / 183 | 272 / 61 | 2M | 5M |
| Q2 2025 | 602 | 27M | 94.7% | 76 / 224 | 227 / 54 | 4M | 3M |
| Q1 2025 | 585 | 26M | 91.3% | 68 / 234 | 212 / 69 | 3M | 2M |
| Q4 2024 | 592 | 25M | 90.7% | 100 / 216 | 210 / 82 | 3M | 3M |
| Q3 2024 | 584 | 26M | 91.5% | 72 / 245 | 198 / 106 | 5M | 3M |
| Q2 2024 | 623 | 26M | 91.9% | 76 / 238 | 235 / 43 | 3M | 3M |
| Q1 2024 | 595 | 26M | 93.9% | 95 / 185 | 247 / 40 | 3M | 2M |
| Q4 2023 | 544 | 25M | 90.0% | 96 / 201 | 182 / 34 | 3M | 2M |
| Q3 2023 | 488 | 24M | 85.7% | 74 / 154 | 186 / 45 | 3M | 3M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
542 funds held MEDP in Q2 2026, 52% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of MEDP | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 772,113 | 2.76% | $408.90M | 0.33% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 724,942 | 2.59% | $383.92M | 0.02% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 523,659 | 1.87% | $277.32M | 0.15% | Jun 30, 2026 |
| T. Rowe Price Large-Cap Growth Fund | 376,363 | 1.35% | $199.32M | 0.97% | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 302,065 | 1.08% | $159.97M | 0.34% | Jun 30, 2026 |
| Invesco S&P MidCap Quality ETF | 295,760 | 1.06% | $170.69M | 3.13% | Jul 31, 2026 |
| Vanguard Explorer Fund | 269,615 | 0.96% | $155.60M | 0.70% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 258,774 | 0.93% | $137.04M | 0.14% | Jun 30, 2026 |
| Fullerthaler Behavioral Small Cap Equity | 173,049 | 0.62% | $91.65M | 0.72% | Jun 30, 2026 |
| iShares Biotechnology ETF | 163,042 | 0.58% | $86.35M | 0.95% | Jun 30, 2026 |
| Wasatch Core Growth Fund | 136,556 | 0.49% | $72.32M | 2.42% | Jun 30, 2026 |
| Bridge Builder Large Cap Growth Fund | 136,183 | 0.49% | $72.12M | 0.24% | Jun 30, 2026 |
| iShares Russell Mid-Cap Growth ETF | 135,882 | 0.49% | $71.96M | 0.33% | Jun 30, 2026 |
| iShares S&P Mid-Cap 400 Growth ETF | 134,962 | 0.48% | $71.47M | 0.63% | Jun 30, 2026 |
| Invesco S&P MidCap Momentum ETF | 122,494 | 0.44% | $70.69M | 0.99% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| August J. Troendle | President & CEO, Director, 10% owner | 5,071,244 | 18.13% | Oct 1, 2026 |
| Stephen P. Ewald | General Counsel & Corp. Secy. | 19,098 | 0.07% | Nov 2, 2026 |
| Susan E. Burwig | Exec. VP, Operations | 54,012 | 0.19% | Oct 28, 2026 |
| Kevin M. Brady | CFO & Treasurer | 12,830 | 0.05% | Aug 24, 2026 |
| Brad W. Hansman | Exec. VP, Operations | 697 | 0.00% | Jun 4, 2026 |
| Jesse J. Geiger | President | 46,707 | 0.17% | Mar 19, 2026 |
| Robert O. Kraft | Director | 987 | 0.00% | Oct 2, 2026 |
| Cornelius P. McCarthy III | Director | 12,303 | 0.04% | Oct 2, 2026 |
| Brian T. Carley | Director | 27,861 | 0.10% | Oct 2, 2026 |
| Fred B. Davenport Jr | Director | 11,259 | 0.04% | Aug 21, 2026 |
| Dani S. Zander | Director | – | – | May 18, 2026 |
| Femida H. Gwadry-Sridhar | Director | – | – | May 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Stephen P. Ewald General Counsel & Corp. Secy. | Oct 29, 2026 | Sale | −1,245 | $690.00 | $859.05K | 19,098 |
| Susan E. Burwig Exec. VP, Operations | Oct 27, 2026 | Sale | −3,940 | $677.00 | $2.67M | 54,012 |
| Susan E. Burwig Exec. VP, Operations | Oct 26, 2026 | Option exercise | +328 | $166.73 | $54.69K | 57,952 |
| Susan E. Burwig Exec. VP, Operations | Oct 26, 2026 | Sale | −16,060 | $677.00 | $10.87M | 57,624 |
| Susan E. Burwig Exec. VP, Operations | Oct 21, 2026 | Option exercise | +2,700 | $166.73 | $450.17K | 73,684 |
| Susan E. Burwig Exec. VP, Operations | Oct 12, 2026 | Option exercise | +3,000 | $166.73 | $500.19K | 70,984 |
| Susan E. Burwig Exec. VP, Operations | Oct 7, 2026 | Option exercise | +2,000 | $166.73 | $333.46K | 67,984 |
| Cornelius P. McCarthy III Director | Sep 30, 2026 | Option exercise | +28 | – | – | 12,303 |
| Brian T. Carley Director | Sep 30, 2026 | Option exercise | +36 | – | – | 27,861 |
| Robert O. Kraft Director | Sep 30, 2026 | Option exercise | +32 | – | – | 987 |
| August J. Troendle President & CEO, Director, 10% owner | Sep 30, 2026 | Sale | −21,966 | $625.47 | $13.74M | 338,225 |
| August J. Troendle President & CEO, Director, 10% owner | Sep 29, 2026 | Sale | −26,701 | $621.02 | $16.58M | 360,191 |
| August J. Troendle President & CEO, Director, 10% owner | Sep 28, 2026 | Sale | −2,410 | $620.07 | $1.49M | 386,892 |
| August J. Troendle President & CEO, Director, 10% owner | Sep 25, 2026 | Sale | −154 | $620.60 | $95.57K | 389,302 |
| August J. Troendle President & CEO, Director, 10% owner | Sep 24, 2026 | Sale | −27,833 | $621.33 | $17.29M | 389,456 |
| August J. Troendle President & CEO, Director, 10% owner | Sep 23, 2026 | Sale | −16,083 | $628.64 | $10.11M | 417,289 |
| August J. Troendle President & CEO, Director, 10% owner | Sep 22, 2026 | Sale | −49,018 | $628.11 | $30.79M | 433,372 |
| August J. Troendle President & CEO, Director, 10% owner | Sep 21, 2026 | Sale | −21,883 | $623.29 | $13.64M | 482,390 |
| August J. Troendle President & CEO, Director, 10% owner | Sep 17, 2026 | Sale | −10,880 | $620.40 | $6.75M | 504,273 |
| August J. Troendle President & CEO, Director, 10% owner | Sep 16, 2026 | Sale | −8,770 | $621.29 | $5.45M | 515,153 |
| August J. Troendle President & CEO, Director, 10% owner | Sep 15, 2026 | Sale | −15,971 | $620.84 | $9.92M | 523,923 |
| Susan E. Burwig Exec. VP, Operations | Sep 15, 2026 | Option exercise | +3,000 | $166.73 | $500.19K | 65,984 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 27, 2026 | Sale | −650 | $620.27 | $403.18K | 539,894 |
| Robert O. Kraft Director | Aug 26, 2026 | Option exercise | +3,858 | $84.36 | $325.46K | 4,813 |
| Robert O. Kraft Director | Aug 26, 2026 | Sale | −3,858 | $617.81 | $2.38M | 955 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 26, 2026 | Sale | −4,000 | $620.03 | $2.48M | 540,544 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 25, 2026 | Sale | −673 | $620.38 | $417.52K | 544,544 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 24, 2026 | Sale | −1,983 | $620.23 | $1.23M | 545,217 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 21, 2026 | Sale | −13,995 | $624.45 | $8.74M | 547,200 |
| Kevin M. Brady CFO & Treasurer | Aug 20, 2026 | Sale | −3,400 | $625.24 | $2.13M | 12,830 |
| Kevin M. Brady CFO & Treasurer | Aug 20, 2026 | Option exercise | +3,400 | $138.87 | $472.16K | 16,230 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 20, 2026 | Sale | −27,174 | $618.79 | $16.81M | 561,195 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 19, 2026 | Sale | −15,609 | $606.47 | $9.47M | 588,369 |
| Brian T. Carley Director | Aug 19, 2026 | Sale | −5,000 | $608.63 | $3.04M | 27,825 |
| Fred B. Davenport Jr Director | Aug 19, 2026 | Option exercise | +3,858 | $84.36 | $325.46K | 9,259 |
| Fred B. Davenport Jr Director | Aug 19, 2026 | Option exercise | +1,822 | $164.68 | $300.05K | 11,081 |
| Fred B. Davenport Jr Director | Aug 19, 2026 | Sale | −7,283 | $606.15 | $4.41M | 3,798 |
| Fred B. Davenport Jr Director | Aug 19, 2026 | Option exercise | +1,903 | $133.87 | $254.75K | 5,401 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 13, 2026 | Sale | −458 | $600.39 | $274.98K | 603,978 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 12, 2026 | Sale | −11,366 | $601.53 | $6.84M | 604,436 |
| Cornelius P. McCarthy III Director | Aug 11, 2026 | Sale | −1,140 | $605.37 | $690.12K | 12,275 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 11, 2026 | Sale | −17,610 | $605.11 | $10.66M | 615,802 |
| August J. Troendle President & CEO, Director, 10% owner | Aug 10, 2026 | Sale | −5,534 | $601.53 | $3.33M | 633,412 |
| Cornelius P. McCarthy III Director | Aug 7, 2026 | Sale | −795 | $585.07 | $465.13K | 13,415 |
| Cornelius P. McCarthy III Director | Aug 7, 2026 | Option exercise | +3,858 | $84.36 | $325.46K | 14,210 |
| Susan E. Burwig Exec. VP, Operations | Jul 28, 2026 | Sale | −7,500 | $600.00 | $4.50M | 62,984 |
| August J. Troendle President & CEO, Director, 10% owner | Jul 28, 2026 | Sale | −3,510 | $600.01 | $2.11M | 638,946 |
| August J. Troendle President & CEO, Director, 10% owner | Jul 27, 2026 | Sale | −3,728 | $600.85 | $2.24M | 642,456 |
| Brian T. Carley Director | Jun 30, 2026 | Option exercise | +36 | – | – | 32,825 |
| Cornelius P. McCarthy III Director | Jun 30, 2026 | Option exercise | +28 | – | – | 10,352 |
| Robert O. Kraft Director | Jun 30, 2026 | Option exercise | +33 | – | – | 955 |
| Stephen P. Ewald General Counsel & Corp. Secy. | May 28, 2026 | Sale | −16,349 | $450.00 | $7.36M | 20,343 |
| Stephen P. Ewald General Counsel & Corp. Secy. | May 28, 2026 | Option exercise | +16,349 | $138.87 | $2.27M | 36,692 |
| Kevin M. Brady CFO & Treasurer | Apr 24, 2026 | Option exercise | +7,000 | $138.87 | $972.09K | 12,830 |
| Stephen P. Ewald General Counsel & Corp. Secy. | Apr 24, 2026 | Option exercise | +3,500 | $138.87 | $486.05K | 20,343 |
| Cornelius P. McCarthy III Director | Mar 31, 2026 | Option exercise | +29 | – | – | 10,324 |
| Brian T. Carley Director | Mar 31, 2026 | Option exercise | +36 | – | – | 32,789 |
| Robert O. Kraft Director | Mar 31, 2026 | Option exercise | +33 | – | – | 922 |
| Susan E. Burwig Exec. VP, Operations | Mar 18, 2026 | Option exercise | +12,000 | $166.73 | $2.00M | 70,484 |
| Jesse J. Geiger President | Mar 17, 2026 | Option exercise | +31,707 | $138.87 | $4.40M | 46,707 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Medpace's stock actually held short. Settlement fails (shares not delivered on time) peaked at 994 shares on Aug 24, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Stephen P. Ewald Officer | Oct 29, 2026 | 1,245 | $859.05K | Oct 29, 2026 | Stock Option Exercise |
| Susan E. Burwig Officer | Oct 27, 2026 | 3,940 | $2.67M | Oct 27, 2026 | Stock Option Exercise |
| Susan E. Burwig Officer | Oct 26, 2026 | 16,060 | $10.87M | Oct 26, 2026 | Stock Option Exercise |
| Robert O. Kraft Director | Aug 26, 2026 | 3,858 | $2.38M | Aug 26, 2026 | Stock Option Exercise |
| Kevin M. Brady Officer | Aug 20, 2026 | 3,400 | $2.13M | Aug 20, 2026 | Stock Option Exercise |
| Brian T. Carley Director | Aug 19, 2026 | 5,000 | $3.04M | Aug 19, 2026 | Restricted Stock Vesting |
| Fred B. Davenport Jr Director | Aug 19, 2026 | 7,283 | $4.41M | Aug 19, 2026 | Stock Option Exercise |
| Cornelius P. McCarthy III Director | Aug 11, 2026 | 1,140 | $690.12K | Aug 11, 2026 | Stock Option Exercise |
| Cornelius P. McCarthy III Director | Aug 7, 2026 | 795 | $465.13K | Aug 7, 2026 | Stock Option Exercise |
| Jesse J. Geiger Former Officer | Jul 29, 2026 | 11,000 | $6.95M | Jul 23, 2026 | Stock Option Exercise |
| Jesse J. Geiger Former Officer | Jul 28, 2026 | 4,000 | $2.40M | Jul 28, 2026 | Stock Option Exercise |
| Susan E. Burwig Officer | Jul 28, 2026 | 7,500 | $4.50M | Jul 28, 2026 | Stock Option Exercise |
| August J. Troendle Chairman | Jul 27, 2026 | 307,959 | $184.78M | Jul 27, 2026 | NQ stock options |
| Jesse J. Geiger Former Officer | Jul 23, 2026 | 11,000 | $6.95M | Jul 23, 2026 | Stock Option Exercise |
| Stephen P. Ewald Officer | May 28, 2026 | 16,349 | $7.36M | May 28, 2026 | Option Granted - 02/15/2022 |
Congress trades
22 trades in Medpace reported by 6 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| David J. Taylor OH02 | Bought | May 15, 2026 | $1K–15K | May 28, 2026 |
| David J. Taylor OH02 | Bought | May 15, 2026 | $1K–15K | May 28, 2026 |
| David J. Taylor OH02 | Bought | Feb 26, 2026 | $1K–15K | Mar 6, 2026 |
| David J. Taylor OH02 | Bought | Jan 29, 2026 | $1K–15K | Feb 2, 2026 |
| David J. Taylor OH02 | Sold | Jan 16, 2026 | $1K–15K | Feb 2, 2026 |
| Gilbert Cisneros CA31 | Sold | Jan 15, 2026 | $15K–50K | Feb 13, 2026 |
| Gilbert Cisneros CA31 | Sold (part) | Oct 9, 2025 | $1K–15K | Nov 18, 2025 |
| Lisa McClain MI09 · spouse | Sold | Aug 4, 2025 | $1K–15K | Sep 12, 2025 |
| Gilbert Cisneros CA31 | Sold (part) | Jul 24, 2025 | $1K–15K | Aug 14, 2025 |
| David J. Taylor OH02 | Sold | Jul 23, 2025 | $1K–15K | Sep 2, 2025 |
| Lisa McClain MI09 · spouse | Bought | Jul 22, 2025 | $1K–15K | Aug 13, 2025 |
| Rob Bresnahan PA08 · joint account | Sold | Jan 13, 2025 | $1K–15K | Feb 13, 2025 |
| Josh Gottheimer NJ05 · joint account | Sold (part) | Jul 26, 2024 | $1K–15K | Aug 15, 2024 |
| Josh Gottheimer NJ05 · joint account | Sold (part) | Jun 21, 2024 | $1K–15K | Jul 9, 2024 |
| Josh Gottheimer NJ05 · joint account | Sold (part) | Jan 24, 2024 | $1K–15K | Feb 15, 2024 |
| Michael Patrick Guest MS03 · spouse | Bought | Nov 13, 2023 | $1K–15K | Dec 11, 2023 |
| Josh Gottheimer NJ05 | Sold (part) | Jul 22, 2022 | $1K–15K | Aug 29, 2022 |
| Josh Gottheimer NJ05 · joint account | Sold (part) | Oct 26, 2021 | $1K–15K | Nov 15, 2021 |
| Gilbert Cisneros CA31 | Bought | Dec 10, 2020 | $1K–15K | Jan 11, 2021 |
| Josh Gottheimer NJ05 · joint account | Bought | Dec 8, 2020 | $1K–15K | Jan 7, 2021 |
| Gilbert Cisneros CA31 | Bought | Nov 3, 2020 | $1K–15K | Nov 5, 2020 |
| Josh Gottheimer NJ05 · joint account | Bought | Oct 29, 2020 | $1K–15K | Nov 5, 2020 |
See a number that looks wrong?